Lobe Sciences Ltd. (CSE:LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
Dec 5, 2025, 10:14 AM EST
166.67%
Market Cap 10.78M
Revenue (ttm) n/a
Net Income (ttm) -5.32M
Shares Out 269.49M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,666
Average Volume 64,857
Open 0.0400
Previous Close 0.0400
Day's Range 0.0350 - 0.0400
52-Week Range 0.0150 - 0.0800
Beta 0.20
RSI 46.33
Earnings Date Dec 22, 2025

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

In 2024, Lobe Sciences's revenue was 136,205, a decrease of -83.80% compared to the previous year's 840,534. Losses were -4.42 million, -6.09% less than in 2023.

Financial Statements

News

There is no news available yet.